Armata Pharmaceuticals, Inc. Common Stock (ARMP)
R&D Expenses
$25.59M
TTM · Period ending: · USD
ARMP R&D Expenses
Latest reported$25.59Mperiod ending
Latest reported$25.59Mperiod ending
ARMP TTM R&D Expenses ($0.00 → $25.59M)
TTM R&D Expenses
High-resolution chart · PNG
ARMP r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 13,100,000 | |
| 13,000,000 | |
| 12,600,000 | |
| 13,100,000 | |
| 12,200,000 | |
| 11,500,000 | |
| 10,700,000 | |
| 9,000,000 | |
| 8,600,000 | |
| 8,200,000 | |
| 7,700,000 | |
| 7,700,000 | |
| 7,400,000 | |
| 5,400,000 | |
| 3,600,000 | |
| 1,700,000 | |
| 0 | |
| 0 |